EIG
Evercore ISI Group Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
701
Vitesse Energy
VTS
$986M
|
SR
Stephen Richardson
| $25.54 | $25 |
2%
downside
| Neutral | 2 years ago |
|
702
Marvell Technology
MRVL
$54.6B
|
CJM
C J Muse
| $63.33 | $70 |
11%
upside
| Outperform | 2 years ago |
|
703
NVIDIA
NVDA
$4.07T
|
CM
C Muse
| $167.02 | $50 |
70%
downside
| Outperform | 2 years ago |
|
704
Dorian LPG
LPG
$1.33B
|
SM
Sean Morgan
| $31.09 | $32 |
3%
upside
| Outperform | 2 years ago |
|
705
Applied Materials
AMAT
$130B
|
CJM
C J Muse
| $162.75 | $135 |
17%
downside
| Outperform | 2 years ago |
|
706
Gen Digital
GEN
$18.2B
|
PL
Peter Levine
| $29.50 | $27 |
8%
downside
| Outperform | 2 years ago |
|
707
Alphabet (Google) Class C
GOOG
$2.84T
|
MM
Mark Mahaney
| $235.17 | $130 |
45%
downside
| Outperform | 2 years ago |
|
|
708
NVIDIA
NVDA
$4.07T
|
CJM
C J Muse
| $167.02 | $32 |
81%
downside
| Outperform | 2 years ago |
|
709
Sprouts Farmers Market
SFM
$13.6B
|
MM
Michael Montani
| $138.83 | $29 |
79%
downside
| Underperform | 2 years ago |
|
710
BridgeBio Pharma
BBIO
$10.2B
|
JS
Josh Schimmer
| $53.38 | $40 |
25%
downside
| Outperform | 2 years ago |
|
711
Avidity Biosciences
RNA
$6.48B
|
JS
Joshua Schimmer
| $50.36 | $20 |
60%
downside
| In-Line | 2 years ago |
|
712
PVH
PVH
$4.22B
|
OS
Omar Saad
| $87.76 | $100 |
14%
upside
| In-Line | 2 years ago |
|
713
Astria Therapeutics
ATXS
$424M
|
LB
Liisa Bayko
| $7.52 | $18 |
139%
upside
| Outperform | 2 years ago |
|
714
Hershey
HSY
$37.6B
|
DP
David Palmer
| $185.48 | $255 |
37%
upside
| In-Line | 2 years ago |
|
715
Chart Industries
GTLS
$8.96B
|
JW
James West
| $199.45 | $217 |
9%
upside
| Outperform | 2 years ago |
|
716
Neurocrine Biosciences
NBIX
$14.3B
|
JS
Joshua Schimmer
| $144.10 | $130 |
10%
downside
| Outperform | 2 years ago |
|
717
Denali Therapeutics
DNLI
$2.26B
|
JS
Joshua Schimmer
| $15.43 | $50 |
224%
upside
| Outperform | 2 years ago |
|
718
RingCentral
RNG
$2.89B
|
PL
Peter Levine
| $31.94 | $40 |
25%
upside
| In-Line | 2 years ago |
|
719
Allstate
ALL
$53.1B
|
DM
David Motemaden
| $201.53 | $138 |
32%
downside
| In-Line | 2 years ago |
|
720
TG Therapeutics
TGTX
$5.11B
|
JS
Joshua Schimmer
| $32.21 | $25 |
22%
downside
| Outperform | 2 years ago |
|
721
Consolidated Edison
ED
$35.4B
|
DC
Durgesh Chopra
| $98.05 | $92 |
6%
downside
| In-Line | 2 years ago |
|
722
Altimmune
ALT
$334M
|
LB
Liisa Bayko
| $3.78 | $25 |
561%
upside
| Outperform | 2 years ago |
|
723
Lucid Motors
LCID
$5.66B
|
CM
Chris McNally
| $18.41 | $120 |
552%
upside
| In-Line | 2 years ago |
|
724
Regency Centers
REG
$13.4B
|
SK
Samir Khanal
| $73.68 | $68 |
8%
downside
| In-Line | 2 years ago |
|
|
725
Neurocrine Biosciences
NBIX
$14.3B
|
JS
Josh Schimmer
| $144.10 | $130 |
10%
downside
| In-Line | 2 years ago |
|